The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

Protective Effect of Lonicerae Flos Aqueous Extracts on a Pressure Overload-induced Heart Failure Model

  • Shin, Jae-wook (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Oriental Hospital of Daegu Haany University) ;
  • Jang, Woo-seok (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Oriental Hospital of Daegu Haany University) ;
  • Baek, Kyung-min (Dept. of Cardiovascular and Neurologic Diseases of Korean Internal Medicine, Daegu Oriental Hospital of Daegu Haany University)
  • Received : 2017.09.11
  • Accepted : 2017.12.17
  • Published : 2017.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Lonicerae flos (LF), a dried flower part of Lonicera japonica Thunb., has been widely used in Korean medicine as anti-inflammatory and antioxidative agent. The purpose of this study was to determine the cardioprotective effects of LF, through potential antioxidant effects, on the pressure overload (PO)-induced heart failure (HF) in C57BL/6 mice after transverse aortic constriction (TAC) surgery. Methods: Resveratrol (10 mg/kg body weight) or LF (125, 250 or 500 mg/kg body weight) was orally administered, once daily for 14 days, starting 14 days after TAC surgery. Changes in the mortality, body weights, heart weights, histopathology of the heart, and antioxidant defense systems of the heart were analyzed. Results: Marked and noticeable increases of heart weights, mortalities, and hypertrophic, focal, and lytic fibrotic histological changes in the LVs were observed, with destruction of heart antioxidant defense systems after surgery. However, HF signs, induced by TAC surgery through PO, and destruction of heart antioxidant defense systems were significantly and dose-dependently inhibited by 14 days of maintained oral treatment with LF 500, 250 or 125 mg/kg. Treatment with 250 mg/kg LF was comparable to treatment with 10 mg/kg resveratrol. Conclusions: The results in this study suggest that oral administration of LF favorably relieves PO-induced HF following TAC, through increase of heart antioxidant defense systems. The overall effects of 250 mg/kg LF were similar to those of 10 mg/kg resveratrol. More detailed mechanistic studies should be conducted in the future, with screening of the biologically active compounds in LF.

Keywords

References

  1. Braunwald E. The war against heart failure: the Lancet lecture. Lancet 2015;385(9970):812-24. https://doi.org/10.1016/S0140-6736(14)61889-4
  2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2012 update: a report from the American Heart Association. Circulation 2012; 125(1):e2-e220.
  3. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37(27):2129-200. https://doi.org/10.1093/eurheartj/ehw128
  4. Munzel T, Gori T, Keaney JF, Maack C, Daiber A. Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. European Heart Journal 2015;36(38) :2555-64. doi:10.1093/eurheartj/ehv305.
  5. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganlats TG, et al. 2009 Focused update incorporated in to the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the international Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53(15):e1-e90. https://doi.org/10.1016/j.jacc.2008.11.013
  6. Ezekowitz JA, Kaul P, Bakal JA, Quan H, McAlister FA. Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? Eur J Heart Fail 2011;13(2) :142-7. doi:10.1093/eurjhf/hfq185.
  7. Ku SK, Seo BI, Park JH, Park GY, Seo YB, Kim JS, et al. Effect of Lonicerae Flos extracts on reflux esophagitis with antioxidant activity. World J Gastroenterol 2009;15(38):4799-805. https://doi.org/10.3748/wjg.15.4799
  8. Ku SK, Lee YJ. Effects of Lonicerae Flos on the 6-n-propyl-2-thiouracil (PTU)-induced rat hyperthyroidism. Korean J Orient Physiol Pathol 2010;24(4):630-7.
  9. Tian J, Che H, Ha D, Wei Y, Zheng S. Characterization and anti-allergic effect of a polysaccharide from the flower buds of Lonicera japonica. Carbohydrate Polymers 2012;90(4):1642-7. https://doi.org/10.1016/j.carbpol.2012.07.044
  10. Elliott PJ, Jirousek M. Sirtuins: novel targets for metabolic disease. Curr Opin Investig Drugs 2008;9(4):371-8.
  11. Dolinsky VW, Chan AY, Robillard Frayne I, Light PE, Des Rosiers C, Dyck JR. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1. Circulation 2009;119(12):1643-52. https://doi.org/10.1161/CIRCULATIONAHA.108.787440
  12. Rimbaud S, Ruiz M, Piquereau J, Mateo P, Fortin D, Veksler V, et al. Resveratrol Improves Survival, Hemodynamics and Energetics in a Rat Model of Hypertension Leading to Heart Failure. PloS one 2011;6(10):e26391. https://doi.org/10.1371/journal.pone.0026391
  13. Lan W, Zhaojun Z, Zesheng Z. Characterization of antioxidant activity of extracts from Flos Lonicerae. Drug Dev Ind Pharm 2007;33(8):841-7. https://doi.org/10.1080/03639040701378019
  14. Gupta PK, DiPette DJ, Supowit SC. Protective effect of resveratrol against pressure overloadinduced heart failure. Food Sci Nutr 2014;2(3):218-29. https://doi.org/10.1002/fsn3.92
  15. Qi J, Liu Q, Gong K, Yu J, Wang L, Guo L, et al. Apocynum tablet protects against cardiac hypertrophy via inhibiting AKT and ERK1/2 phosphorylation after pressure overload. Evid Based Complement Alternat Med 2014;2014:769515.
  16. Songstad NT, Johansen D, How OJ, Kaaresen PI, Ytrehus K, Acharya G. Effect of transverse aortic constriction on cardiac structure, function and gene expression in pregnant rats. PLoS One 2014;9(2):e89559. https://doi.org/10.1371/journal.pone.0089559
  17. van Empel VP, Bertrand AT, van Oort RJ, van der Nagel R, Engelen M, van Rijen HV, et al. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. J Am Coll Cardiol 2006;48(4):824-32. https://doi.org/10.1016/j.jacc.2006.02.075
  18. Bento DB, de Souza B, Steckert AV, Dias RO, Leffa DD, Moreno SE, et al. Oxidative stress in mice treated with antileishmanial meglumine antimoniate. Res Vet Sci 2013;95(3):1134-41. https://doi.org/10.1016/j.rvsc.2013.08.004
  19. Fox JG, Cohen BJ, Loew FM. Laboratory animal medicine. Orlando: Academic Press Inc; 1984.
  20. Tajima Y (Ed). Biological reference data book on experimental animals. Tokyo: Soft Science Inc; 1989.
  21. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003;65:45-79. https://doi.org/10.1146/annurev.physiol.65.092101.142243
  22. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011;58(25):e212-60. https://doi.org/10.1016/j.jacc.2011.06.011
  23. Juric D, Wojciechowski P, Das DK, Netticadan T. Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol. Am J Physiol Heart Circ Physiol 2007;292(5):H2138-43. https://doi.org/10.1152/ajpheart.00852.2006
  24. Wojciechowski P, Juric D, Louis XL, Thandapilly SJ, Yu L, Taylor C, et al. Resveratrol arrests and regresses the development of pressure overloadbut not volume overload-induced cardiac hypertrophy in rats. J Nutr 2010;140(5):962-8. https://doi.org/10.3945/jn.109.115006
  25. Yu S, Li G. MicroRNA expression and function in cardiac ischemic injury. J Cardiovasc Transl Res 2010;3(3):241-5. https://doi.org/10.1007/s12265-010-9168-8
  26. Dai DF, Hsieh EJ, Liu Y, Chen T, Beyer RP, Chin MT, et al. Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress. Cardiovasc Res 2012;93(1):79-88. https://doi.org/10.1093/cvr/cvr274
  27. Koga K, Kenessey A, Ojamaa K. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol 2013;304(2):H282-93. https://doi.org/10.1152/ajpheart.00595.2012
  28. Odabasoglu F, Cakir A, Suleyman H, Aslan A, Bayir Y, Halici M, et al. Gastroprotective and antioxidant effects of usnic acid on indomethacininduced gastric ulcer in rats. J Ethnopharmacol 2006;103(1):59-65. https://doi.org/10.1016/j.jep.2005.06.043
  29. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull 1993; 49(3):481-93. https://doi.org/10.1093/oxfordjournals.bmb.a072625
  30. Zhou Y, Zhou T, Pei Q, Liu S, Yuan H. Pharmacokinetics and tissue distribution study of chlorogenic Acid from lonicerae japonicae flos following oral administrations in rats. Evid Based Complement Alternat Med 2014;2014:979414.